MDS continues to expand and diversify in line with the company’s long-term growth objective.

Investor Updates

   

Committed to Agility

We focus on providing an unparalleled experience in our customer interactions and a world-class offering that will delight our partners, fulfil our work family, enrich our shareholders and better the communities we serve.

2025 Business REVIEW
On the strategic front, MDS is progressing with investments in logistics, inventory control systems, and tighter credit screening processes to bolster efficiency and tighten financial controls.

During the fiscal year ended March 31, 2025, Medical Disposables & Supplies Limited (MDS) achieved revenue of J$3.88 billion, reflecting growth of J$174.79 million (or 4.71%).
This growth was driven by a strong recovery in the second half of the year, supported by higher sell-through across the Pharmaceutical, Medical and Consumer Divisions.
The expansion of consumer goods distribution, including confectionery lines and pet care, contributed to incremental volume and market diversification.

Gross profit increased to J$876.4 million from J$713.9 million in the prior year.
The previous year was impacted by a substantial write-down of slow-moving and near-dated inventory due to supply chain difficulties in previous periods.
This means that in real terms, gross profit increased by J$76 million or 10.64% as the company moved to protect margins through improved supply chain management controls.
While the company reported an operating loss in the year, it marked a J$24 million improvement over the prior year, reflecting a move in the right direction.

Financial Highlights

3.88B

JMD

Revenue

876.40M

JMD

Gross Profit

56%

Profit Increase

1.1B

JMD

Shareholders’ Equity

87.01M

JMD

Increase in Equity

3.42B

Revenue

936.46M

Gross Profit

56%

Profit Increase

1.1B

Shareholders’ Equity

87.01M

Increase in Equity

Results and reports

We are pleased to have you as a shareholder and grateful for the confidence you have demonstrated by entrusting us with your investment. We have, and will always, strive to create value for you, our shareholders, over the long term.

2022 Financial Report (Consolidated)

Corporate Governance Board Charter

2025 Annual Report

While COVID-19 radically and rapidly changed how the world does business, it also slowed the usual feverish pace, giving us a rare opportunity to review, reimagine the possibilities and clean our business lens to focus - or refocus our focus - on lesser rabbits but greater outcomes. While being the biggest giant in the industry can be alluring, it is not the rabbit we have decided to pursue. Rather, our hunt is focused on being the best. In furtherance of this outlook, we strengthened our resolve in becoming even closer to our market and understanding what our customers need and value. Through introspection, we have been reminded of our strengths and have been better able to connect this with the business environment and our customers at large with one of our most prized being that of ‘focus’.

medical disposables & supplies

Business Unusal

We focus on providing an unparalleled experience in our customer interactions and a world-class offering that will delight our partners, fulfil our work family, enrich our shareholders and better the communities we serve.